Similar companies
| Company | Business Outlook | |
|---|---|---|
 |
AmgenAMGN |
76 0% |
 |
Gilead SciencesGILD |
54 1.8% |
 |
Catalyst PharmaceuticalsCPRX |
100 0% |
 |
Inovio PharmaceuticalsINO |
23 0% |
 |
Anavex Life SciencesAVXL |
0 0% |
Month over Month
Employee view on business outlook (0 - 100)
| Mar 2025 | 83 | |
| Feb 2025 | 83 | |
| Jan 2025 | 83 | |
| Dec 2024 | 83 |
How do employees feel about the future at Revolution Medicines?
The Business Outlook at Revolution Medicines is very positive according to its employees. The average outlook rating of 91 (out of 100) is very high according to data from the top review sites in the US. This rating is also up by 9.6% since the last month.
Analyzing Business Outlook, how is Revolution Medicines performing compared to its industry peers?
Revolution Medicines overperforms a majority of its industry peers when it comes to Business Outlook, ranking in the 91st percentile.
How has the business outlook at Revolution Medicines changed over the last couple of months
In recent months, Revolution Medicines' employees have reported a shift towards a more positive business outlook, indicating improved company morale and potentially leading to increased market competitiveness and enhanced company performance.
Why is it important to track the business outlook at Revolution Medicines?
Tracking a company's business outlook is important as a positive outlook can indicate future growth and profitability and attract new talent, while a negative outlook can discourage talent and imply demotivated employees. Additionally, data shows that companies with a high business outlook tend to perform better on the stock market compared to those with a lower business outlook.
Sign up and get more insights on the business outlook at Revolution Medicines.
